Therefore, well-designed studies that adjust for these variables provide more reliable safety signals than early uncontrolled analyses
Research has shown that GLP-1 receptor agonists can help reduce liver fat and inflammation
But awareness is also needed amongst the general public as well as in health professionals, to recognise the signs, so that they Think Aorta and request the right test at the right time
I had to ask, Is the GLP-1 use to manage Type II Diabetes and lower A1C or to enhance the weight loss benefit to the patient? Additionally, at least one study shows that patients likely need to be on GLP-1s long-term to sustain weight loss, as the risk of regaining the initial weight loss plus an extra 10-15% in body weight is possible
Understanding these risks allows you to be more prepared for what might happen and to seek help from your healthcare provider if needed
Why are compounded GLP-1s created